Pay in 4 interest-free payments of $143.12 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
PubMed PMID: 25550133
In cellular mechanistic assays
with IC50 of 50-100 nM
3-dioxoisoindolin-4-yl)amino)butyl)amino)-4-oxobutyl)-1H-1
DT2216 inhibits various BCL-XL-dependent leukemia and cancer cells but considerably less toxic to platelets
BCX 4430 Size:Solid 10 mg PubMed PMID: 25550133Galidesivir, also known as BCX4430 and Immucillin A, is an antiviral drug and an adenosine analog. Galidesivir was originally intended as a treatment for Hepatitis C, but subsequently developed as a potential treatment for deadly filovirus infections such as Ebola virus disease and Marburg virus disease. Galidesivir also shows broad spectrum antiviral effectiveness against a range of other RNA virus families, including bunyaviruses, arenaviruses,
US$ 68.00
US$ 48.00
US$ 38.00
US$ 65.00
US$ 50.55
US$ 38.00
US$ 38.00
US$ 88.00
US$ 38.00
US$ 38.00
US$ 38.00